Use of local anesthetics in individuals with chronic renal failure
Uso de anestésicos locais em indivíduos com insuficiência renal crônica
Palavras-chave:
Renal Failure, Systemic Arterial Hypertension, Local AnestheticsResumo
Individuals with chronic renal failure (CRF) undergoing hemodialysis often develop systemic arterial hypertension (SAH) and have to consider which anesthetic should be used in dental interventions. The objective of this study was to evaluate the action of anesthetics with (AV) and without vasoconstrictor (AWV) in individuals with CRF, in need of dental treatment. Randomly, dental hemiarchs were subjected to anesthetic infiltration with a 1.8 mL tube (for one moment with AV and another moment AWV). Oxygen saturation (SaO2), heart rate (HR), systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured before and after anesthesia. The results demonstrated a statistical difference only in SaO2 5 minutes after anesthesia in comparison with the AV and AWV groups, highlighting the safety of its use, as long as in small quantities, in individuals with CRF.
Downloads
Referências
BAILARD, N. S.; ORTIZ, J.; FLORES, R. A. Additives to local anesthetics for peripheral nerve blocks: Evidence, limitations, and recommendations. American Journal of Health-System Pharmacy, 2014.
BARBOSA, J. B. N. et al. Quality of life and duration of hemodialysis in patients with chronic kidney disease (CKD): a cross-sectional study. Fisioterapia em Movimento, v. 30, n. 4, 2017.
BETHESDA, M. US Renal Data Service. USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States., 2009.
BREIVIK, HARALD, A. S. Management of acute postoperative pain: Still a long way to go ! v. 137, p. 233–234, 2008.
BRITO, F. et al. Extent and severity of chronic periodontitis in chronic kidney disease patients. Journal of Periodontal Research, v. 47, n. 4, 2012.
CHANG, G. H. et al. End-stage renal disease: A risk factor of deep neck infection - a nationwide follow-up study in Taiwan. BMC Infectious Diseases, v. 17, n. 1, 2017.
COSTA, F. G.; COUTINHO, M. DA P. DE L.; SANTANA, I. O. DE. Insuficiência renal crônica: representações sociais de pacientes com e sem depressão. Psico-USF, v. 19, n. 3, p. 387–398, dez. 2014.
DE PAULA, E. A. et al. Strengths of primary healthcare regarding care provided for chronic kidney disease1. Revista Latino-Americana de Enfermagem, v. 24, 2016.
DYLEWSKA, M.; WIELICZKO, M. [Anemia in chronic kidney disease--reasons and treatment]. Wiadomosci Lekarskie, v. 67, n. 3, 2014.
GREFFIN, S. et al. Chronic kidney disease and metabolic syndrome as risk factors for cardiovascular disease in a primary care program. Jornal Brasileiro de Nefrologia, v. 39, n. 3, 2017.
HARADA, P. H. N. et al. Pericardial fat is associated with coronary artery calcification in non-dialysis dependent chronic kidney disease patients. PLoS ONE, v. 9, n. 12, 2014.
HUNG, S. C. et al. Association of fluid retention with anemia and clinical outcomes among patients with chronic kidney disease. Journal of the American Heart Association, v. 4, n. 1, 2015.
KIM, Y. J. et al. Evaluation of periodontal condition and risk in patients with chronic kidney disease on hemodialysis. Einstein (Sao Paulo, Brazil), v. 15, n. 2, 2017.
LAMMERS, E. et al. Does the combination of 3% mepivacaine plain plus 2% lidocaine with epinephrine improve anesthesia and reduce the pain of anesthetic injection for the inferior alveolar nerve block? A prospective, randomized, double-blind study. Journal of endodontics, v. 40, n. 9, 2014.
MARUTHINGAL, S. et al. A comparative evaluation of 4% articaine and 2% lidocaine in mandibular buccal infiltration anesthesia: A clinical study. Journal of International Society of Preventive and Community Dentistry, v. 5, n. 6, 2015.
MOODY, W. E. et al. Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: Cause or association? Atherosclerosis, 2012.
MOREIRA, J. M. et al. Neuropsychiatric disorders and renal diseases: an update. Jornal brasileiro de nefrologia: ’orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia, v. 36, n. 3, p. 396–400, 1 jul. 2014.
PALLOS, D. et al. Salivary markers in patients with chronic renal failure. Archives of Oral Biology, v. 60, n. 12, 2015.
ROTTEMBOURG, J.; ROSTOKER, G. Use of intravenous iron supplementation in chronic kidney disease: Interests, limits, and recommendations for a better practice. Nephrologie et Therapeutique, 2015.
SALVADOR GONZALEZ, B. et al. [Chronic kidney disease in Primary Health Care: prevalence and associated risk factors]. Atencion primaria, v. 47, n. 4, 2015.
SCARPARO, H. C. et al. Effects of mepivacaine 2% with epinephrine in the cardiovascular activity of patients undergoing third molar surgery: A prospective clinical study. Journal of Craniofacial Surgery, v. 25, n. 1, 2014.
SCHMALZ, G. et al. Oral behavior, dental, periodontal and microbiological findings in patients undergoing hemodialysis and after kidney transplantation. BMC Oral Health, v. 16, n. 1, 2016.
SESSO, R. et al. Relatório do Censo Brasileiro de Diálise, 2008 Brazilian Dialysis Census Report, 2008. Nefrologia, v. 30, n. 4, 2008.
SESSO, R. DE C. C. et al. Diálise Crônica no Brasil - Relatório do Censo Brasileiro de Diálise, 2011 TT - Chronic Dialysis in Brazil - Report of the Brazilian Dialysis Census, 2011. J. bras. nefrol, v. 34, n. 3, 2012.
STAUFFER, M. E.; FAN, T. Prevalence of anemia in chronic kidney disease in the United States. PLoS ONE, v. 9, n. 1, 2014.
TORRES-LAGARES, D. et al. Cardiovascular effect of dental anesthesia with articaine (40 mg with epine-frine 0,5 mg % and 40 mg with epinefrine 1 mg%) versus mepivacaine (30mg and 20 mg with epinefrine 1 mg%) in medically compromised cardiac patients: A cross-over, randomized, single blinded study. Medicina Oral, Patologia Oral y Cirugia Bucal, v. 17, n. 4, 2012.
TRAMINI, P.; MONTAL, S.; VALCARCEL, J. Tooth loss and associated factors in long-term institutionalised elderly patients. Gerodontology, v. 24, n. 4, 2007.
VANHOLDER, R. et al. Reducing the costs of chronic kidney disease while delivering quality health care: A call to action. Nature Reviews Nephrology, 2017.
XU, J. et al. Deaths: Final Data for 2013. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System, v. 64, n. 2, 2016.
